These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4757549)

  • 21. [Intra-arterial infusion chemotherapy for poor-risk patients with locally advanced bladder cancer--clinical assessment of five cases].
    Araki S; Ito H; Numa H; Okada K
    Gan No Rinsho; 1987 Jan; 33(1):54-9. PubMed ID: 3102811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
    Maier U; Baumgartner G
    J Urol; 1989 Mar; 141(3):529-30. PubMed ID: 2493098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop.
    van Helsdingen PJ; Rikken CH
    J Urol; 1986 Aug; 136(2):461-3. PubMed ID: 3090277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of superficial bladder cancer in a community setting.
    Haas JA
    Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
    Iborra Juan I; Ricos Torrent JV; Monrós Lliso JL; Dumont Martínez R; Casanova Ramón-Borja J; Solsona Narbón E
    Arch Esp Urol; 1992 Dec; 45(10):1001-7. PubMed ID: 1294028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Parmar MK; Freedman LS; Hargreave TB; Tolley DA
    J Urol; 1989 Aug; 142(2 Pt 1):284-8. PubMed ID: 2501516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
    Okajima E; Motomiya Y; Ishuin M; Ikuma S; Ohara S
    Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intracavitary instillation for bladder tumor with antitumor agent. 5th Report: Difference of the action of mitomycin C on normal bladder and tumor of the bladder (experimental and clinical study)].
    Ogawa H; Hiraoka Y; Kawai H
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):596-607. PubMed ID: 6413739
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of intravesical mitomycin C in management of superficial bladder tumors.
    Bracken RB; Swanson DA; Johnson DE; De Furia D; von Eschenbach AC; Crooke S
    Urology; 1980 Jul; 16(1):11-5. PubMed ID: 7395004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the treatment of bladder cancer. II. The treatment of progressive bladder cancer with carcinostatic substance infusion into internal iliac artery].
    Nagayama T
    Nihon Hinyokika Gakkai Zasshi; 1971 Dec; 62(12):944-59. PubMed ID: 5169063
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of intravesical instillation of antitumor agents on bladder cancer].
    Tomiyama T
    Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074
    [No Abstract]   [Full Text] [Related]  

  • 33. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W
    Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP; DeBruyne FM
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 36. Severely contracted bladder following intravesical mitomycin C therapy.
    Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
    J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the chemotherapy of cancer of urinary bladder. II. An experimental study on treatment with continuous infusion of anticancer agent into the internal iliac artery].
    Nakamura T
    Nihon Hinyokika Gakkai Zasshi; 1969 Jul; 60(7):657-66. PubMed ID: 5388371
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic use of mitomycin C in bladder cancer.
    Denis L
    Prog Clin Biol Res; 1984; 162B():113-22. PubMed ID: 6438638
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitomycin C therapy in superficial bladder cancer.
    Denis L; Keuppens F; Hendrickx G
    Prog Clin Biol Res; 1985; 185B():113-22. PubMed ID: 3929269
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
    Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.